Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of Novel Gene Signatures using Next-Generation Sequencing Data from COVID-19 Infection Models: Focus on Neuro-COVID and Potential Therapeutics

31 Aug 2021

Abstract excerpt

SARS-CoV-2 is the causative agent for coronavirus disease-19 (COVID-19) and belongs to the family Coronaviridae that causes sickness varying from the common cold to more severe illnesses such as severe acute respiratory syndrome, sudden stroke, neurological complications (Neuro-COVID), multiple organ failure, and mortality in some patients. The gene expression profiles of COVID-19 infection models can be used to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to interferon and immune responses
Share to Long-Term Effects of COVID-19
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34531741
DOI: 10.3389/fphar.2021.688227

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of Novel Gene Signatures using Next-Generation Sequencing Data from COVID-19 Infection Models: Focus on Neuro-COVID and Potential TherapeuticsPMID 34531741Read ↗

Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: insights from machine learning and bioinformatics approachesSemantic proximity Read ↗

Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approachesSemantic proximity Read ↗

Transcriptomic Signatures and Repurposing Drugs for COVID-19 Patients: Findings of Bioinformatics AnalysesSemantic proximity Read ↗

Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samplesSemantic proximity Read ↗

Deciphering Novel SARS CoV-2 specific Disease Pathways from RNA Sequencing Data of COVID-19 Infected A549 Cells and Potential Therapeutics using Next Generation Knowledge Discovery PlatformsSemantic proximity Read ↗

Identification of potential biomarkers and inhibitors for SARS-CoV-2 infectionSemantic proximity Read ↗

Identification of key molecules in COVID-19 patients significantly correlated with clinical outcomes by analyzing transcriptomic dataSemantic proximity Read ↗

Identifying potential novel insights for COVID-19 pathogenesis and therapeutics using an integrated bioinformatics analysis of host transcriptomeSemantic proximity Read ↗

Systems Biology and Bioinformatics approach to Identify blood based signatures molecules and drug targets of patient with COVID-19Semantic proximity Read ↗

Potential therapeutic targets for COVID-19 complicated with pulmonary hypertension: a bioinformatics and early validation studySemantic proximity Read ↗

Deep Learning Analysis of Single-Cell Data Reveals Unique Genetic Features Of COVID-19 SeveritiesSemantic proximity Read ↗

The current status of gene expression profilings in COVID‐19 patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.